Does LORLATINIB Cause Blood thyroid stimulating hormone increased? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Blood thyroid stimulating hormone increased have been filed in association with LORLATINIB (Lorbrena). This represents 0.4% of all adverse event reports for LORLATINIB.
24
Reports of Blood thyroid stimulating hormone increased with LORLATINIB
0.4%
of all LORLATINIB reports
3
Deaths
6
Hospitalizations
How Dangerous Is Blood thyroid stimulating hormone increased From LORLATINIB?
Of the 24 reports, 3 (12.5%) resulted in death, 6 (25.0%) required hospitalization.
Is Blood thyroid stimulating hormone increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORLATINIB. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Blood thyroid stimulating hormone increased?
LEVOTHYROXINE (3,171)
PEMBROLIZUMAB (330)
LENVATINIB (228)
NIVOLUMAB (226)
ALEMTUZUMAB (194)
CABOZANTINIB S-MALATE (164)
AMIODARONE (143)
SUNITINIB MALATE (112)
SOMATROPIN (91)
ATORVASTATIN (71)
Which LORLATINIB Alternatives Have Lower Blood thyroid stimulating hormone increased Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE